{"version":"1.0","type":"link","title":"The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL.","author_name":"Al-Sawaf O 외","author_url":"https://prs-insight.online/author/Al-Sawaf%20O","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/166346","thumbnail_width":1200,"thumbnail_height":630}